Anthem Biosciences Limited is a Contract Research, Development, and Manufacturing Organisation (CRDMO) that prioritises innovation and technology, offering fully integrated services across drug discovery, development, and production.
Anthem Biosciences Limited has submitted its draft red herring prospectus (DRHP) to the Securities and Exchange Board of India (SEBI) as part of its plans to raise capital through an initial public offering (IPO).
The Bangalore-based company’s IPO includes an Offer for Sale (OFS) of equity shares worth up to ₹3,395 crores from the Selling Shareholders.
The promoters of Anthem Biosciences Limited are Ajay Bhardwaj (Chairman, Managing Director & CEO), Ishaan Bhardwaj (Vice President), Ganesh Sambasivam (Executive Director), and K Ravindra Chandrappa (Executive Director).
The Offer for Sale (OFS) includes equity shares amounting to ₹350 crores each from Ganesh Sambasivam and K. Ravindra Chandrappa. Additionally, Viridity Tone LLP is offering equity shares worth up to ₹1,325 crores, while Portsmouth Technologies LLC will offer shares amounting to ₹320 crores.
Moreover, Malay J. Barua, Rupesh N. Kinekar, and Satish Sharma are each selling equity shares valued up to ₹320 crores; Prakash Kariabettan has shares worth up to ₹80 crores for sale; and K. Ramakrishnan will offer shares totalling up to ₹10 crores (classified as Other Selling Shareholders).
In terms of revenue, Anthem Biosciences Limited reported a 34.3% increase in its operational income, rising from ₹1,056 crores in Fiscal 2023 to ₹1,419 crores in Fiscal 2024. The Profit After Tax (PAT) for the year ending March 31, 2024, stood at ₹367 crores.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
We're Live on WhatsApp! Join our channel for market insights & updates
Get the link to download the App
